UNION CITY, Calif., Feb. 23, 2011 /PRNewswire/ — Abaxis, Inc.
(Nasdaq:
ABAX), a medical products company manufacturing point-of-care
blood analysis systems, announced today that Clint Severson,
chairman and chief executive officer, will present at the RBC
Capital Markets’ Healthcare Conference on Thursday, March 3, 2011
at 10:00 a.m. ET. The conference will be held at the New York
Palace Hotel in New York City.
A live webcast of the presentation will be available to all
interested parties on the Abaxis, Inc. website at www.abaxis.com in
the Investor Relations section.
About Abaxis Abaxis develops, manufactures and markets
portable blood analysis systems for use in any veterinary or human
patient-care setting to provide clinicians with rapid blood
constituent measurements. The system consists of a compact, 5.1
kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The system can
be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples. The system provides
test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer.
The webcast will include, statements that constitute
“forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995 (the “Reform Act”),
including but not limited to statements related to Abaxis’ cash
position, financial resources and potential for future growth,
market acceptance and penetration of new or planned product
offerings, and future recurring revenues and results of operations.
Abaxis claims the protection of the safe-harbor for
forward-looking statements contained in t
‘/>”/>
